Your browser doesn't support javascript.
loading
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
Hajiev, Saur; Allara, Elias; Motedayеn Aval, Leila; Arizumi, Tadaaki; Bettinger, Dominik; Pirisi, Mario; Rimassa, Lorenza; Pressiani, Tiziana; Personeni, Nicola; Giordano, Laura; Kudo, Masatoshi; Thimme, Robert; Park, Joong-Won; Taddei, Tamar H; Kaplan, David E; Ramaswami, Ramya; Pinato, David J; Sharma, Rohini.
Afiliação
  • Hajiev S; Division of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
  • Allara E; Division of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
  • Motedayеn Aval L; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Arizumi T; Division of Surgery and Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.
  • Bettinger D; Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
  • Pirisi M; Department of Medicine II, University Medical Center, Freiburg, Germany.
  • Rimassa L; Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Pressiani T; Department of Translational Medicine, Università degli Studi del Piemonte Orientale, Novara, Italy.
  • Personeni N; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.
  • Giordano L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
  • Kudo M; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.
  • Thimme R; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.
  • Park JW; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
  • Taddei TH; Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center-IRCCS, Rozzano (Milan), Italy.
  • Kaplan DE; Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.
  • Ramaswami R; Department of Medicine II, University Medical Center, Freiburg, Germany.
  • Pinato DJ; National Cancer Centre Hospital, Goyang, South Korea.
  • Sharma R; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Br J Cancer ; 124(2): 407-413, 2021 01.
Article em En | MEDLINE | ID: mdl-33071284

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Sorafenibe / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article